EGFR and adenocarcinoma: Although EGFR mutation has been reported in non-adenocarcinoma lung cancer, particularly in squamous cell carcinoma (SCC), the PFS of EGFR-TKIs for EGFR mutated lung SCC was shorter than the patients with EGFR mutated adenocarcinoma [34].